| 5.65 0.02 (0.36%) | 06-16 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.97 | 1-year : | 8.14 |
| Resists | First : | 5.96 | Second : | 6.97 |
| Pivot price | 4.99  |
|||
| Supports | First : | 4.6 | Second : | 3.75 |
| MAs | MA(5) : | 5.57 |
MA(20) : | 4.84 |
| MA(100) : | 4.25 |
MA(250) : | 3.13 |
|
| MACD | MACD : | 0.2 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 77.6 |
D(3) : | 82.7 |
| RSI | RSI(14): 64.2 |
|||
| 52-week | High : | 5.96 | Low : | 1.32 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ BFLY ] has closed below upper band by 14.5%. Bollinger Bands are 31.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 5.84 - 5.86 | 5.86 - 5.88 |
| Low: | 5.54 - 5.57 | 5.57 - 5.59 |
| Close: | 5.61 - 5.65 | 5.65 - 5.68 |
Butterfly Network, Inc. functions as a digital health enterprise, specializing in the invention, production, and global commercialization of cutting-edge ultrasound imaging technologies for both domestic and international markets. The company's innovative product portfolio includes the portable Butterfly iQ, a versatile single-probe system capable of whole-body ultrasound imaging, and the Butterfly iQ+, a point-of-care ultrasound device engineered to connect effortlessly with smartphones, tablets, and existing hospital computer networks. Additionally, Butterfly Blueprint is offered as a comprehensive, system-wide ultrasound platform that seamlessly integrates its proprietary Compass software into a healthcare provider's clinical and administrative infrastructure. These ultrasound systems, encompassing probes, related accessories, and software subscriptions, are supplied to healthcare systems, individual physicians, and other medical professionals through a multi-channel distribution strategy that includes a direct sales force, a network of distributors, and an e-commerce platform. Beyond its hardware, Butterfly Network provides a suite of cloud-based software solutions for healthcare organizations. These offerings feature teleguidance services, interactive in-app educational modules, and structured training programs delivered via its Butterfly Academy software, all complemented by dedicated clinical support and services. Established in 2011, Butterfly Network, Inc. has its corporate headquarters situated in Guilford, Connecticut.
Sun, 14 Jun 2026
Q1 2025 Butterfly Network Inc Earnings Call Transcript - GuruFocus
Thu, 11 Jun 2026
Don't Ignore The Insider Selling In Butterfly Network - simplywall.st
Thu, 11 Jun 2026
Butterfly Network to Participate in TD Cowen’s Medical Devices Emerging Growth Call Series on June 18, 2026 - Business Wire
Tue, 09 Jun 2026
Butterfly Network (BFLY) CBO Steve Cashman sells 399,461 shares in open market - Stock Titan
Mon, 08 Jun 2026
Director Steven Cashman sells Class A shares (BFLY) in Form 144 notice - Stock Titan
Mon, 08 Jun 2026
Butterfly Network (BFLY) affiliate reports 452,299-share disposals, RSUs listed - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 235 (M) |
| Shares Float | 193 (M) |
| Held by Insiders | 12.1 (%) |
| Held by Institutions | 55.7 (%) |
| Shares Short | 27,150 (K) |
| Shares Short P.Month | 24,140 (K) |
| EPS | -0.31 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.73 |
| Profit Margin | -73.7 % |
| Operating Margin | -50.9 % |
| Return on Assets (ttm) | -11.2 % |
| Return on Equity (ttm) | -35.2 % |
| Qtrly Rev. Growth | 25 % |
| Gross Profit (p.s.) | 0.28 |
| Sales Per Share | 0.43 |
| EBITDA (p.s.) | -0.22 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -15 (M) |
| Levered Free Cash Flow | 9 (M) |
| PE Ratio | -18.84 |
| PEG Ratio | 0 |
| Price to Book value | 7.73 |
| Price to Sales | 12.91 |
| Price to Cash Flow | -89.08 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|